Navigation Links
Strongest proof yet found for prion hypothesis

UTMB scientists offer strongest evidence yet that infectious misformed proteins cause mad cow disease and other mysterious brain disorders

Researchers at the University of Texas Medical Branch at Galveston (UTMB) have produced the strongest proof yet that the mysterious and devastating brain diseases known as "transmissible spongiform encephalopathies" (TSEs) are transmitted by an infectious agent composed only of a malformed protein, and not a virus. TSEs, which can afflict both human beings and animals, include mad cow disease, new-variant Creutzfeldt-Jakob Syndrome, scrapie, kuru and chronic wasting disease.

This controversial "prion hypothesis" was proposed by Stanley Prusiner in 1982, and led to Prusiner receiving the Nobel Prize in Medicine in 1997. Until now, however, scientists have been unable to confirm its validity by causing a TSE in normal lab animals by infecting them with malformed proteins (dubbed "prions" by Prusiner) created entirely in a test tube. Such an approach eliminates the possibility that some other agent might be causing the disease.

In a paper scheduled to appear in the journal Cell on April 21, the UTMB researchers describe the use of a method they developed called "protein misfolding cyclic amplification" (PMCA) to vastly accelerate the activity of a small number of prions taken from infected hamsters and placed in test tubes containing healthy brain proteins. When the healthy proteins had been largely transformed into prions, the samples were diluted over and over again and the process repeated, until the only remaining prions were those that had been generated in the test tubes. These were then injected into the brains of healthy hamsters, which began showing TSE symptoms within four months and, on average, died less than six months after inoculation.

"For many years, people have tried to make these infectious prions in test tubes, because what is needed to prove the prion hypothesis completely is to be able to produce this process in vitro in the absence of living cells and thus rule out the presence of a virus," said Claudio Soto, professor of neurology at UTMB and senior author of the paper. "The evidence in favor of the prion hypothesis was strong, but the final proof was still missing. Now we have supplied this proof."

Soto emphasized that a tremendous increase in efficiency of the PMCA technology played a crucial role in the work of his team, which included study co-authors Joaquín Castilla, Paula Saá and Claudio Hetz. By mimicking the natural mechanism of prion formation but doing so at a much higher rate, PMCA made it possible to produce the large quantities of prion protein necessary for the success of the experiments and opened the door to further TSE studies. According to Soto, it should also soon facilitate creating a much-needed blood test for prions, which would greatly improve current surveillance techniques for mad cow disease and its human form, new-variant Creutzfeldt-Jakob Syndrome.


'"/>

Source:University of Texas Medical Branch


Related biology news :

1. Experiments provide proof of how traveling in groups protects insects
2. Experiments provide proof of how traveling in groups protects insects
3. Scientists find fossil proof of Egypts ancient climate
4. Researchers offer proof-of-concept for Altered Nuclear Transfer
5. New component of the brakes on nerve regeneration found
6. A puzzle piece found in unraveling the wiring of the brain
7. New World founders small in number
8. Norovirus found to cause travelers diarrhea
9. Pair of cancer genes found to drive both cell migration and division
10. Alien woodwasp, threat to US pine trees, found in N.Y.
11. Achilles heel of the herpes virus possibly found
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at Trinity ... for graphene by combining the material with Silly ... sensitive pressure detector able to sense pulse, blood ... small spider.  The research team,s ... be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/18/2017)...   Boston Biomedical , an industry leader in ... stemness pathways, will feature data from two clinical studies ... ASCO Gastrointestinal Cancers Symposium, held from January 19-21, in ... Napabucasin is an orally-administered investigational agent designed to inhibit ... stem cells (CSCs) possess the property of stemness – ...
(Date:1/18/2017)... ... January 18, 2017 , ... Whitehouse ... expertise. Within Albany Molecular Research, Inc. (AMRI), the scientific staff dedicated to Extractables ... is planned for further growth in 2017. Extractable & Leachable evaluations have become ...
(Date:1/18/2017)... Chicago, IL (PRWEB) , ... January 18, 2017 ... ... auction on January 24th, 2017, to sell research and genetic testing lab equipment ... of service in the Northwest and Northeast regions of the United States. This ...
(Date:1/18/2017)... 18, 2017  Caris Life Sciences, a leading ... the largest private funder of pancreatic cancer research, ... the impact of immunotherapy in the treatment of ... services to identify potential trial candidates based on ... physicians and study investigators. The Lustgarten Foundation is ...
Breaking Biology Technology: